Cargando…

Comparison of Sentinel Lymph Node Biopsy by Blue Dye Conjunction With Indocyanine Green or Radioisotope in Early-Stage Breast Cancer: A Prospective Single-Center Observational Study

BACKGROUND: Although radioisotope (RI) combined with blue dye (BD) is the standard technique for sentinel lymph node (SLN) biopsy in breast cancer, the use of RI is limited at some institutions due to the specific equipment needed. Indocyanine green (ICG) fluorescence detection has been developed as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yanmei, Peng, Qing, Sun, Pengcheng, Li, Xuesha, Dong, Yilong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Navigating Breast Health: From Screening to Survivorship
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624060/ https://www.ncbi.nlm.nih.gov/pubmed/37928452 http://dx.doi.org/10.1177/11795549231201129

Ejemplares similares

Efficacy and Safety of Dual Anti-HER2 Blockade and Docetaxel With or Without Carboplatin as Neoadjuvant Regimen for Treatment of HER2-Positive Breast Cancer
por: Lin, Binwei, et al.
Publicado: (2023)

Clinicopathologic Features and Prognosis of Female Early Breast Cancer With HER2 Low Expression: A Propensity Score Matched Analysis
por: Dai, Lanyi, et al.
Publicado: (2023)

Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer: The GREENORBLUE Trial
por: Nguyen, Chu Luan, et al.
Publicado: (2023)

Meta-analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye-Guided Sentinel Node Identification for Breast Cancer Surgery
por: Kedrzycki, Martha S., et al.
Publicado: (2020)

Sentinel lymph node biopsy after neoadjuvant treatment of breast cancer using blue dye, radioisotope, and indocyanine green: Prospective cohort study
por: Chirappapha, Prakasit, et al.
Publicado: (2020)

The combination of blue dye and radioisotope versus radioisotope alone during sentinel lymph node biopsy for breast cancer: a systematic review
por: He, Pei-Sheng, et al.
Publicado: (2016)

Comparison of sentinel lymph node detection performances using blue dye in conjunction with indocyanine green or radioisotope in breast cancer patients: a prospective single-center randomized study
por: Yuan, Long, et al.
Publicado: (2018)

Diagnostic Performance of Indocyanine Green Plus Methylene Blue Versus Radioisotope Plus Methylene Blue Dye Method for Sentinel Lymph Node Biopsy in Node-Negative Early Breast Cancer
por: Agrawal, Sanjit Kumar, et al.
Publicado: (2020)

Indocyanine Green Fluorescence Versus Blue Dye or Radioisotope Regarding Detection Rate of Sentinel Lymph Node Biopsy and Nodes Removed in Breast Cancer: A Systematic Review and Meta-Analysis
por: Thongvitokomarn, Sarun, et al.
Publicado: (2020)

ASO Author Reflections: Comparison of Indocyanine Green with Blue Dye in Sentinel Lymph Node Biopsy for Cutaneous Melanoma
por: Fadel, Michael G., et al.
Publicado: (2023)

Impact of Sentinel Lymph Node Biopsy on Treatment Decision and Survival in Patients Aged ≥70 Years with Breast Cancer: A Retrospective Study
por: Gu, Chongshan, et al.
Publicado: (2022)

Comparative Study Between Radioisotope Uptake and Fluorescence Intensity of Indocyanine Green for Sentinel Lymph Node Biopsy in Breast Cancer
por: Kang, Byeongju, et al.
Publicado: (2022)

Indocyanine Green Lymphangiography: An Alternative to Blue Dye Detection for Sentinel Lymph Node Biopsy in Cutaneous Malignancies of the Head and Neck
por: Parham, Christopher S., et al.
Publicado: (2019)

ASO Author Reflections: Indocyanine Green Fluorescence Sentinel Lymph Node Biopsy in Breast Cancer—An Alternative to Blue Dye?
por: Nguyen, Chu Luan, et al.
Publicado: (2023)

Randomized Comparison of Near-infrared Fluorescence Imaging Using Indocyanine Green and 99(m) Technetium With or Without Patent Blue for the Sentinel Lymph Node Procedure in Breast Cancer Patients
por: van der Vorst, Joost R., et al.
Publicado: (2012)

Preliminary study of contrast-enhanced ultrasound in combination with blue dye vs. indocyanine green fluorescence, in combination with blue dye for sentinel lymph node biopsy in breast cancer
por: Zhou, Yidong, et al.
Publicado: (2019)

Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer
por: Guo, Wenbin, et al.
Publicado: (2014)

A Longitudinal Comparison of Arm Morbidity in Stage I–II Breast Cancer Patients Treated with Sentinel Lymph Node Biopsy, Sentinel Lymph Node Biopsy Followed by Completion Lymph Node Dissection, or Axillary Lymph Node Dissection
por: Kootstra, Jan J., et al.
Publicado: (2010)

Omitting Sentinel Lymph Node Biopsy in Elderly Patients: A Lost Opportunity?
por: Tuttle, Todd M., et al.
Publicado: (2021)

Comparative study of indocyanine green combined with blue dye with methylene blue only and carbon nanoparticles only for sentinel lymph node biopsy in breast cancer
por: Qin, Xingsong, et al.
Publicado: (2019)

A Prospective Self-Controlled Study of Indocyanine Green, Radioisotope, and Methylene Blue for Combined Imaging of Axillary Sentinel Lymph Nodes in Breast Cancer
por: Jin, Yuting, et al.
Publicado: (2022)

Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ
por: Killelea, Brigid K., et al.
Publicado: (2018)

Biphasic anaphylactic reaction to blue dye during sentinel lymph node biopsy
por: Liang, Margaret I, et al.
Publicado: (2008)

Sentinel Lymph Node Mapping and Biopsy in Breast Cancer Patients During the COVID-19 Pandemic
por: Cocco, Daniela, et al.
Publicado: (2021)

Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study
por: Guo, Jiajia, et al.
Publicado: (2017)

Application of fluorescence endoscopy with methylene blue dye and indocyanine green dual-tracer method in sentinel lymph node biopsy for women with breast cancer
por: Ou, Caifeng, et al.
Publicado: (2023)

Evaluation of indocyanine green combined with methylene blue staining in sentinel lymph node biopsy of breast cancer
por: Xu, Yong, et al.
Publicado: (2022)

The Lymphatic Anatomy of the Breast and its Implications for Sentinel Lymph Node Biopsy: A Human Cadaver Study
por: Suami, Hiroo, et al.
Publicado: (2007)

Internal Mammary Sentinel Lymph Node Biopsy in Clinically Axillary Lymph Node-Positive Breast Cancer: Diagnosis and Implications for Patient Management
por: Qiu, Peng-Fei, et al.
Publicado: (2019)

The Use of Wearable Activity Monitors to Measure Upper Limb Physical Activity After Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy
por: Che Bakri, Nur Amalina, et al.
Publicado: (2023)

Survival After Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection for Female Patients with T3-4c Breast Cancer
por: Li, Peiyong, et al.
Publicado: (2023)

Is blue dye still required during sentinel lymph node biopsy for breast cancer?
por: Peek, Mirjam CL, et al.
Publicado: (2016)

Comparison of the indocyanine green dye method versus the combined method of indigo carmine blue dye with indocyanine green fluorescence imaging for sentinel lymph node biopsy in breast conservative therapy for stage ≤IIA breast cancer
por: Takemoto, Nobuyuki, et al.
Publicado: (2018)

Clinical study of combined application of indocyanine green and methylene blue for sentinel lymph node biopsy in breast cancer
por: Zhang, Chenguang, et al.
Publicado: (2021)

Risk of Regional Recurrence After Negative Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor Recurrence
por: Poodt, Ingrid G. M., et al.
Publicado: (2018)

A Randomized Prospective Non-Inferiority Trial of Sentinel Lymph Node Biopsy in Early Breast Cancer: Blue Dye Compared with Indocyanine Green Fluorescence Tracer
por: Coibion, Michel, et al.
Publicado: (2022)

Cancer nutrition and rehabilitation—its time has come!
por: Chasen, M.R., et al.
Publicado: (2008)

Healing and survivorship: what makes a difference?
por: Braude, H.D., et al.
Publicado: (2008)

Workplace support for employees with cancer
por: Nowrouzi, B., et al.
Publicado: (2009)

Informational stories: a complementary strategy for patients and caregivers with brain metastases
por: Chung, A.D., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_butm4ki1fn78fqpaje80fk0mql